Imperial Collage Healthcare

Vedolizumab Trough level

Test Background
Vedolizumab (Entyvio©) is a humanised IgG1 antibody which inhibits the action of the mucosal trafficking α4β7 integrin and prevents migration of inflammatory T cells to the gut. Vedolizumab levels are measured in serum taken from patients just before an infusion (trough) using an indirect ELISA coated with α4β7 integrin

Clinical Indications
For the monitoring of drug trough levels in IBD patients treated with Vedolizumab

Reference Range

Results are reported between 0.8µg/ml and 144 µg/ml.  In the induction phase of the Entyvio© clinical trials week 6 trough levels were higher in responders than non-responders and higher trough levels were associated with increased mucosal healing in UC patients.

Sample Required

Sample Container
Rust Top Vacutainer

Sample Collection
Samples should be taken just before the next infusion of drug (trough)

Sample Volume

Transportation at room temperature/ first class post is adequate. Storage at 4 degrees or -20 for long term.

Turnaround Time
4 weeks

Filter by A-Z

Select a test from the left to view more details.